Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat

European Journal of Pharmacology

Volumn 666, Issue 1-3, 2011, Pages 135-141

  Garjani, Alireza ^a   Andalib, Sina ^a   Biabani, Sajjad ^a   Soraya, Hamid ^a   Doustar, Yousef ^b   Garjani, Afagh ^a   Maleki Dizaji, Nasrin ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Atorvastatin; Coenzyme Q10; Heart failure; Isoproterenol

Indexed keywords

ATORVASTATIN; UBIDECARENONE; UBIQUINON; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFECT; DRUG MEGADOSE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE RELAXATION; HEART MUSCLE COMPLIANCE; HEART MUSCLE FIBROSIS; HEART MUSCLE NECROSIS; HEART RATE; HEMODYNAMIC PARAMETERS; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BODY WEIGHT; DRUG INTERACTIONS; HEART FAILURE; HEMODYNAMICS; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ISOPROTERENOL; MALE; MYOCARDIUM; ORGAN SIZE; PYRROLES; RATS; RATS, WISTAR; UBIQUINONE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79960013321     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.04.061     Document Type: Article

References (37)

1. I.J. Benjamin, J.E. Jalil, L.B. Tan, K. Cho, K.T. Weber, and W.A. Clark Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis Circ. Res. 65 1989 657 670 (Pubitemid 19226442)
2. S.A. Chang, Y.J. Kim, H.W. Lee, D.H. Kim, H.K. Kim, H.J. Chang, D.W. Sohn, B.H. Oh, and Y.B. Park Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy Hypertension 54 2009 591 597
3. G. De Pinieux, P. Chariot, M. Ammi-Said, F. Louran, J.L. Lejonc, A. Astier, B. Jacotot, and R. Gherardi Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio Br. J. Clin. Pharmacol. 42 1996 333 337 (Pubitemid 26284422)
4. A. Garjani, C.L. Wainwright, I.J. Zeitlin, C. Wilson, and S.J. Slee Effects of endothelin-1 and the ETA-receptor antagonist, BQ123, on ischaemic arrhythmias in anaesthetized rats J. Cardiovas. Pharmacol. 25 1995 634 642
5. S.A. Glynn, D. O'Sullivan, A.J. Eustace, M. Clynes, and N. O'Donovan The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells BMC Cancer 16 2008 8 9
6. J.L. Goldstein, and M.S. Brown Regulation of the mevalonate pathway Nature 343 1990 425 430
7. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial Lancet 361 2003 2005 2016
8. C. Indolfi, E. Di Lorenzo, C. Perrino, A.M. Stingone, A. Curcio, D. Torella, A. Cittadini, L. Cardone, C. Coppola, L. Cavuto, O. Arcucci, L. Sacca, E.V. Avvedimento, and M. Chiariello Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation Circulation 106 2002 2118 2124 (Pubitemid 35192819)
9. A.M. James, R.A. Smith, and M.P. Murphy Antioxidant and prooxidant properties of mitochondrial coenzyme Q Arch. Biochem. Biophys. 423 2004 47 56 (Pubitemid 38198212)
10. B.H. Jiang, J.C. Tardif, S. Sauvageau, A. Ducharme, Y. Shi, J.G. Martin, and J. Dupuis Beneficial effects of atorvastatin on lung structural remodeling and function in ischemic heart failure J. Card. Fail. 16 2010 679 688
11. J. Kjekshus, E. Apetrei, V. Barrios, M. Bohm, J.G. Cleland, J.H. Cornel, P. Dunselman, C. Fonseca, A. Goudev, P. Grande, L. Gullestad, A. Hjalmarson, J. Hradec, A. Janosi, G. Kamensky, M. Komajda, J. Korewicki, T. Kuusi, F. Mach, V. Mareev, J.J. McMurray, N. Ranjith, M. Schaufelberger, J. Vanhaecke, D.J. van Veldhuisen, F. Waagstein, H. Wedel, and J. Wikstrand Rosuvastatin in older patients with systolic heart failure N. Engl. J. Med. 357 2007 2248 2261 (Pubitemid 350190755)
12. J.C. LaRosa, S.M. Grundy, D.D. Waters, C. Shear, P. Barter, J.C. Fruchart, A.M. Gotto, H. Greten, J.J. Kastelein, J. Shepherd, N.K. Wenger Treating to New Targets (TNT) Investigators Intensive lipid lowering with atorvastatin in patients with stable coronary disease N. Engl. J. Med. 352 2005 1425 1435 (Pubitemid 40471450)
13. M.R. Law, N.J. Wald, and A.R. Rudnicka Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis BMJ 326 2003 1423
14. J.K. Liao Statin therapy for cardiac hypertrophy and heart failure J. Investig. Med. 52 2004 248 253 (Pubitemid 39360341)
15. M.J. Lipinski, C.A. Cauthen, G.L. Biondi-Zoccai, A. Abbate, B. Vrtovec, B.V. Khan, and G.W. Vrtovec Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure Am. J. Cardiol. 104 2009 1708 1716
16. M. Liu, F. Wang, Y. Wang, and R. Jin Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation Cardiovasc. Drugs Ther. 23 2009 369 376
17. D. Loch, S. Levick, A. Hoey, and L. Brown Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats J. Cardiovasc. Pharmacol. 47 2006 396 404 (Pubitemid 44309693)
18. J.D. Luo, W.W. Zhang, G.P. Zhang, J.X. Guan, and X. Chen Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis Clin. Exp. Pharmacol. Physiol. 26 1999 903 908 (Pubitemid 29513630)
19. J.J. McMurray, P. Dunselman, H. Wedel, J.G. Cleland, M. Lindberg, A. Hjalmarson, J. Kjekshus, F. Waagstein, E. Apetrei, V. Barrios, M. Böhm, G. Kamenský, M. Komajda, V. Mareev, J. Wikstrand CORONA Study Group Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure) J. Am. Coll. Cardiol. 56 2010 1196 1204
20. S.A. Mortensen Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio"-a multinational trial Biofactors 18 2003 79 89 (Pubitemid 38030702)
21. S.A. Mortensen, A. Leth, E. Agner, and M. Rohde Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors Mol. Aspects Med. 18 1997 137 144
22. Ojha, S.; Goyal, S.; Kumari, S.; Arya, D.S.; in press. Pyruvate attenuates cardiac dysfunction and oxidative stress in isoproterenol-induced cardiotoxicity. Exp. Toxicol. Pathol. http://www.sciencedirect.com/science/ article/pii/S0940299310001673.
23. S. Pepe, S.F. Marasco, S.J. Haas, F.L. Sheeran, H. Krum, and F.L. Rosenfeldt Coenzyme Q10 in cardiovascular disease Mitochondrion 7 2007 S154 S167
24. C.G. Proud Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy Cardiovasc. Res. 63 2004 403 413 (Pubitemid 38970184)
25. R. Zhou, Q. Xu, P. Zheng, L. Yan, J. Zheng, and G. Dai Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat Eur. J. Pharmacol. 586 2008 244 250
26. T. Rundek, A. Naini, R. Sacco, K. Coates, and S. DiMauro Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke Arch. Neurol. 61 2004 889 892 (Pubitemid 38747328)
27. M. Saka, K. Obata, S. Ichihara, X.W. Cheng, H. Kimata, A. Noda, H. Izawa, K. Nagata, and M. Yokota Attenuation of ventricular hypertrophy and fibrosis in rats by pitavastatin: potential role of the RhoA-extracellular signal regulated kinase-serum response factor signalling pathway Clin. Exp. Pharmacol. Physiol. 33 2006 1164 1171 (Pubitemid 44923903)
28. J. Shepherd, S.M. Cobbe, I. Ford, C.G. Isles, A.R. Lorimer, P.W. MacFarlane, J.H. McKillop, and C.J. Packard Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N. Engl. J. Med. 333 1995 1301 1307
29. M.A. Silver, P.H. Langsjoen, S. Szabo, H. Patil, and A. Zelinger Effects of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction Am. J. Cardiol. 94 2004 1306 1310 (Pubitemid 39469957)
30. S. Sola, M.Q. Mir, S. Lerakis, N. Tandon, and B.V. Khan Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure J. Am. Coll. Cardiol. 47 2006 332 337 (Pubitemid 43063250)
31. T.E. Strandberg, I. Holme, O. Faergeman, J.J. Kastelein, C. Lindahl, M.L. Larsen, A.G. Olsson, T.R. Pedersen, M.J. Tikkanen IDEAL Study Group Comparative effect of atorvastatin (80 mg) versus simvastatin (20 to 40 mg) in preventing hospitalization for heart failure in patients with previous myocardial infarction Am. J. Cardiol. 15 2009 1381 1385
32. P.H. Sugden Ras, Akt, and mechanotransduction in the cardiac myocyte Circ. Res. 93 2003 1179 1192 (Pubitemid 37543058)
33. D. Susic, J. Varagic, J. Ahn, M. Slama, and E.D. Frohlich Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models J. Am. Coll. Cardiol. 42 2003 1091 1097 (Pubitemid 37108599)
34. L. Tavazzi, A.P. Maggioni, R. Marchioli, S. Barlera, M.G. Franzosi, R. Latini, D. Lucci, G.L. Nicolosi, M. Porcu, and G. Tognoni Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial Lancet 372 2008 1231 1239
35. B. Vrtovec, R. Okrajsek, A. Golicnik, M. Ferjan, V. Starc, T.T. Schlegel, and B. Radovancevic Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure J. Card. Fail. 14 2008 140 144 (Pubitemid 351312881)
36. G.F. Watts Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin J. Clin. Pathol. 46 1993 1055 1057 (Pubitemid 23349243)
37. T. Yamada, K. Node, T. Mine, T. Morita, H. Kioka, Y. Tsukamoto, S. Tamaki, M. Masuda, K. Okuda, and M. Fukunami Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study Am. Heart J. 153 2007 1051 1058